Quantitative Remote Patient Monitoring with Artificial Intelligence (AI) Analysis

BeCareLink provides validated, quantitative measurements of neurological function and cognition that improve the care of Multiple Sclerosis patients and patients with other similar neurological conditions.

BeCareLink is giving patients and doctors the tools to enhance the monitoring of neurologic functions and bothersome symptoms to improve therapeutic decisions.

BeCare Link is a remote Patient Monitoring Platform for neurologic disease.  By assessing their neurologic function at home through the quantitative measures obtained with the use of the BeCare app, patients are empowered to monitor their clinical progress and strengthen the bonds with their physicians.  Data collected from the gamified activities can guide acute and long-term therapies for an individual and provide important data for clinical trials to advance treatment for all MS patients.

An industry renowned team has replicated and supplemented existing manual “Gold Standard” office based processes with mobile and home based administered solutions.

In the care of Multiple Sclerosis patients, the BeCareLink Artificial Intelligence (AI) Digital Therapeutics platform transforms the traditional Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Functional Composite (MSFC) scoring system into a high precision measurement of disease status  and treatment outcomes.

BeCare MS Link

Patients use the mobile App while participating in their daily activities. This real time data provides a more accurate picture of how patients are impacted by their disease, its symptoms, how the disease progresses and the impact of their treatment in real life situations.

Real Time Assessment Of Multiple Sclerosis

Functional systems tested:

  • Motor
  • Cerebellar
  • Gait
  • Balance
  • Color vision
  • Sensation
  • Cognition Mood

Data Collection on:

  • Diet
  • Exercise
  • Sleep Patterns
  • Medication and Family History
  • Most bothersome symptoms

BeCare ALS – Coming Soon